Skip to main content

Month: February 2025

Innofactor wins contract to provide the case and document management system for Gävle Municipality

Innofactor Plc press release February 25, 2025, at 10:00 Finnish time Gävle Municipality is taking an important step towards making the management of documents and cases both simpler and more efficient. Through a carefully conducted procurement process, the municipality chose Innofactor Dynasty, gaining a system that is not only easy to use but also simplifies everyday life for both employees and citizens. The new system will streamline case management, making everything from saving documents and opening new cases to meeting management more efficient. With clear roles and responsibilities, stability and security are created, contributing to a well-functioning and reliable administration. Additionally, Innofactor’s experts will be available to provide professional service and support, focusing on high quality. “With our extensive experience...

Continue reading

Karolinska Development’s portfolio company AnaCardio includes first patient in a phase 2a study of its drug candidate AC01

STOCKHOLM, SWEDEN February 25, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has dosed the first patient in the phase 2a part of the GOAL-HF1 clinical study. The study will evaluate AnaCardio’s drug candidate AC01 in patients with heart failure and reduced ejection fraction. Study results from GOAL-HF1 are expected by the end of the year. AnaCardio AB is a privately held Swedish clinical-stage biopharmaceutical company developing novel drugs to treat heart failure. The company´s lead asset, AC01, is currently being evaluated in a clinical phase 1b/2a study, GOAL-HF1, in patients with heart failure and reduced ejection fraction (HFrEF). The phase 2a part of the GOAL-HF1 study is randomized, double-blind and placebo-controlled, aiming to evaluate the safety, tolerability, pharmacokinetics...

Continue reading

Futu to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

HONG KONG, Feb. 25, 2025 (GLOBE NEWSWIRE) — Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2024, before U.S. markets open on March 13, 2025. Futu’s management will hold an earnings conference call on Thursday, March 13, 2025, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Please note that all participants will need to pre-register for the conference call, using the link https://register.vevent.com/register/BIb8967ae69ba64a7eab0c02d765ce1339. It will automatically lead to the registration page of “Futu Holdings Ltd Fourth Quarter and Full Year 2024 Earnings Conference Call”, where...

Continue reading

New Application Extends Zscaler Exposure Management Solution, Providing a Single Platform for Asset Risk Management, Prioritization and Quantification

SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced the introduction of Zscaler Asset Exposure Management, designed to advance how organizations manage their asset risk, commonly referred to as Cyber Asset Attack Surface Management (CAASM). Serving as a critical foundation for Zscaler’s broader Continuous Threat Exposure Management (CTEM) offerings, this innovative solution consolidates and correlates data from a vast array of sources to deliver to organizations a precise inventory of assets and visibility into their security gaps to mitigate cyber risk. Organizations often struggle to maintain an accurate inventory of their assets. As a result, IT and security teams resort to spending hours using spreadsheets to track assets, making it difficult to...

Continue reading

PCI Biotech: Invitation to preliminary full-year 2024 results presentation

Oslo, Norway, 25 February 2025 – PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company’s full-year 2024 interim report on Thursday 27 February 2025, 08:30am – 09:00am CET (local time).  The presentation will be held as a live webcast available through www.pcibiotech.com. The presentation will be held in Norwegian. There will be a Q&A session at the end of the presentation and it will be possible to post written questions through the webcast console. The interim report and presentation will be made available on www.newsweb.no and on the company’s webpage, www.pcibiotech.com, from 07.00am CET the same day. For further information, please contact:Ronny Skuggedal, CEO / CFOEmail: rs@pcibiotech.noMobile: +47 9400 5757 About PCI Biotech        PCI Biotech is a biopharmaceutical company focusing on developing...

Continue reading

ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy

Study shows significant functional improvements after one year of ARC-EX Therapy Improvements were observed throughout one-year treatment period with no plateau Results demonstrate the importance of sustained access to ARC-EX Therapy EINDHOVEN, the Netherlands, Feb. 25, 2025 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces the publication of positive results from the investigator-sponsored Pathfinder2 Study in Neuromodulation: Technology at Neural Interface. The peer-reviewed paper details findings from a one-year trial demonstrating that ONWARD ARC-EX Therapy combined with activity-based rehabilitation...

Continue reading

BUREAU VERITAS – 2024 annual results – Bureau Veritas’ LEAP | 28 strategy delivers outstanding results in 2024 ; confident 2025 outlook

PRESS RELEASE Neuilly-sur-Seine, France – February 25, 2025 Bureau Veritas’ LEAP | 28 strategy delivers outstanding results in 2024 Confident 2025 outlook 2024 key figuresRevenue of EUR 6,240.9 million in the full year 2024, up 6.4% year-on-year and up 10.2% organically (including 9.6% in the fourth quarter), Adjusted operating profit of EUR 996.2 million, up 7.1% versus EUR 930.2 million in 2023, representing an adjusted operating margin of 16.0%, up 11 basis points year-on-year and up 38 basis points at constant currency, Operating profit of EUR 933.4 million, up 13.2% versus EUR 824.4 million in 2023, Adjusted net profit of EUR 620.7 million, up 8.0% versus EUR 574.7 million in 2023, Attributable net profit of EUR 569.4 million, up 13.0% versus EUR 503.7 million in 2023, Adjusted Earnings Per Share (EPS) of EUR 1.38, up 8.7%...

Continue reading

BlackLine Expands Bengaluru Operations to Drive Global Growth and Innovation

New Office Space Strengthens Customer Support, Scales Global Operations, and Advances Innovation LOS ANGELES, Feb. 25, 2025 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL), the intelligent financial data platform that powers the modern Office of the CFO, announced today the expansion of its presence in Bengaluru, India, reinforcing its commitment to global growth, operational scalability, and continuous, best-in-class customer support. Scaling to Meet Growing Demand Since establishing operations in Bengaluru in 2022, BlackLine has steadily expanded its teams in the region to meet increasing demand for its solutions. The new 50,000-square-foot office strengthens BlackLine’s ability to provide continuous service, accelerate product development, enhance operational efficiencies, and support coverage across multiple time zones. “Our...

Continue reading

Dassault Systèmes Announces Centric Software’s Acquisition of AI-Powered PXM Solution, Contentserv

Press ReleaseVELIZY-VILLACOUBLAY, France — February 25, 2025 Dassault Systèmes Announces Centric Software’s Acquisition of AI-Powered PXM Solution, ContentservContentserv provides the all-in-one cloud-based platform for PIM, DAM, Content Syndication and Digital Shelf Analytics (DSA) Platform enables FMCG companies to craft and optimize product content to reduce time to market, increase product sell-through and curate personalized consumer experiencesDassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that its subsidiary Centric Software, the Product Lifecycle Management (PLM) market leader, has signed an agreement to acquire Contentserv, a leading provider of product information management (PIM) and product experience management (PXM) solutions for an enterprise value of €220 million. Centric Software provides...

Continue reading

Inbank unaudited financial results for Q4 and 12 months of 2024

In 2024, Inbank exhibited strong growth in total net income and net profit, and completed a landmark significant risk transaction (SRT) with the European Investment Bank Group (EIB). In 2024, total net income reached 75.5 million euros, increasing by 26% year-on-year, driven by expanding margins and growing portfolio volumes across both the Baltics and CEE regions. The consolidated net profit for the year amounted to 12.2 million euros, growing 20% year-on-year and return on equity (ROE) was 9%. These results were impacted by one-off items, including a 2.46 million euro cost from closing Inbank’s credit card business, 1.34 million euros in capitalised growth advisory and capital raising fees, and extraordinary profit of 0.66 million euros from the sale of stake in financial technology start-up Paywerk. Excluding all these one-off...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.